BIOT — Bioter SA Share Price
Last trade - 00:00- €4.58m
- €178.18m
- €0.25m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 9.73 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -241.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.18 | 0.25 | 0.23 | 0.25 | 0.25 | n/a | n/a | 6.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bioter S.A. is a Greece-based construction company, which mainly undertakes civil engineering projects for the public sector. The Company’s range of activities includes the construction of buildings, industrial infrastructure and networks, as well as public transportation infrastructure projects. The building construction sector includes sports facilities, exhibition centers, public and governmental buildings, hospitals, hotels, housing complexes, parking stations, shopping malls and office buildings, as well as landscaping. The industrial infrastructure and networks projects include factories, power and electromechanical projects, power and telecommunications networks, refineries, industrial complexes and warehouses, military projects and recycling plants, waste and water treatment facilities, as well as water supply networks. In the field of the public transportation infrastructure projects, the Company undertakes the construction of ports, roads, tunnels, bridges and metro stations.
Directors
- Ioannis Konstantinopoulos CHM (67)
- Georgios Mavroskotis VCH (47)
- Georgios Miligkos CAO
- Aikaterini Liakou DIR
- Konstantina Papa OTH
- Fani Poimenidou OTH
- Georgia Serveta OTH
- Michail Adamantopoulos NED (41)
- Anastasios Sakellaris NED (70)
- Evangelos Stratis NED (69)
- Aristotelis Tsagkarogiannis NED (51)
- Foteini Chatzi NID (46)
- Grigorios Dedes NID (56)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- January 13th, 1962
- Public Since
- August 27th, 1975
- No. of Employees
- 74
- Sector
- Construction & Engineering
- Industry
- Industrials
- Exchange
- Athens Exchange
- Shares in Issue
- 16,727,954
- Address
- Eutihidou Str. 45, ATHINA, 116 34
- Web
- https://bioter.gr/
- Phone
- +30 2107248762
- Contact
- Aikaterini Liakou
- Auditors
- Hellenic Auditing Company SA
Upcoming Events for BIOT
Similar to BIOT
Avax SA
Athens Exchange
Domiki Kritis SA
Athens Exchange
Ekter SA
Athens Exchange
Ellaktor SA
Athens Exchange
GEK Terna SA
Athens Exchange
FAQ
As of Today at 19:04 UTC, shares in Bioter SA are trading at €0.27. This share price information is delayed by 15 minutes.
Shares in Bioter SA last closed at €0.27 and the price had moved by +9.6% over the past 365 days. In terms of relative price strength the Bioter SA share price has outperformed the FTSE Global All Cap Index by +2.89% over the past year.
There is no consensus recommendation for this security.
Bioter SA does not currently pay a dividend.
Bioter SA does not currently pay a dividend.
Bioter SA does not currently pay a dividend.
To buy shares in Bioter SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.27, shares in Bioter SA had a market capitalisation of €4.58m.
Here are the trading details for Bioter SA:
- Country of listing: Greece
- Exchange: ATH
- Ticker Symbol: BIOT
Based on an overall assessment of its quality, value and momentum Bioter SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioter SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +15.7%.
As of the last closing price of €0.27, shares in Bioter SA were trading +1.1% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioter SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.27.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bioter SA's management team is headed by:
- Ioannis Konstantinopoulos - CHM
- Georgios Mavroskotis - VCH
- Georgios Miligkos - CAO
- Aikaterini Liakou - DIR
- Konstantina Papa - OTH
- Fani Poimenidou - OTH
- Georgia Serveta - OTH
- Michail Adamantopoulos - NED
- Anastasios Sakellaris - NED
- Evangelos Stratis - NED
- Aristotelis Tsagkarogiannis - NED
- Foteini Chatzi - NID
- Grigorios Dedes - NID